AB 470 substantially revises Nevada’s prior authorization rules for medical and dental care across a wide range of coverage types, including commercial health insurance, nonprofit hospital and medical/dental service corporations, Medicaid, the Children’s Health Insurance Program, public employee plans, local government self-insurance, and certain private employer self-insured plans. The bill requires health carriers and the Department of Health and Human Services to publish their prior authorization procedures and clinical review criteria online, identify the specific services subject to prior authorization, and give advance notice before changing those procedures. It also shortens decision timelines, generally requiring a response within 48 hours for non-urgent care and 24 hours for urgent care, with even faster action for certain post-stabilization emergency requests.
The bill adds patient- and provider-facing protections. If a carrier is considering denying a request as not medically necessary, it must notify the provider and allow a discussion with the decision-maker before an initial determination. Adverse determinations must include specific reasons, missing documentation, and appeal rights. Approved prior authorizations remain valid for 12 months, or longer for chronic or long-term treatment, and carriers generally may not revoke approvals except in limited circumstances such as fraud, material misrepresentation, or lack of coverage at the time care was provided. The bill also requires carriers to honor certain prior authorizations from a previous insurer during the first 90 days of new coverage, and it deems a request approved if the carrier violates the bill’s procedural requirements.
AB 470 also limits prior authorization for emergency services. Health carriers and Medicaid may not require prior authorization for covered emergency services, may not require notice earlier than the end of the next business day after admission or service, and may not deny medically necessary emergency care. Emergency services are presumed medically necessary if a provider certifies that emergency treatment was required within 72 hours, subject to rebuttal by clear and convincing evidence. For post-evaluation or post-stabilization services, the bill requires a decision within one hour. The bill further directs Medicaid’s Drug Use Review Board to align prescription-drug step therapy and prior authorization policies with these new standards, including special protections for certain psychiatric medications.
The overall sentiment reflected in the bill text is strongly pro-consumer and pro-provider, with a clear policy goal of reducing delays, increasing transparency, and limiting insurer discretion in prior authorization. Although no committee transcript or vote record is provided, the structure of the bill suggests support for patients facing administrative barriers to care, especially for urgent, emergency, and chronic-condition treatment. The fiscal note also indicates potential state and local government impacts, and the bill contains an unfunded mandate for local governments, which may be a practical concern for public employers and government-sponsored plans.
The main points of contention likely involve the administrative and financial burden on insurers, Medicaid administrators, and self-insured public and private plans, as well as the reduced flexibility in utilization management. Carriers may object to the shortened turnaround times, mandatory publication of clinical criteria, automatic approval penalties, and limits on revoking prior authorizations. Providers and patient advocates are likely to support the bill’s transparency and continuity-of-care provisions, while insurers and plan administrators may argue that the bill could increase costs, reduce fraud controls, and constrain medical-necessity review. The bill’s delayed effective date and transition rules suggest an attempt to balance those concerns by giving plans time to update procedures before the new requirements take effect.
AB 470 amends Nevada insurance and Medicaid statutes to impose detailed procedural and substantive limits on prior authorization. It revises NRS 687B.225 and related provisions to require faster response times, online publication of prior authorization rules and clinical criteria, continuity of approvals, emergency-care protections, and disclosure requirements for adverse determinations. It also extends these requirements to nonprofit service corporations, public employee plans, local government self-insurance, private employer self-insurance, and certain managed care arrangements, while creating parallel Medicaid rules in Chapter 422 and directing the Medicaid drug review process to conform to the new standards. The bill is likely to affect insurers, health maintenance organizations, Medicaid contractors, providers, and insureds by changing claims processing, utilization review, and emergency-care authorization practices statewide.
The bill’s policy direction is clearly favorable to patients and providers who have criticized prior authorization as slow and opaque. Even without committee testimony or recorded votes, the text reflects a strong legislative intent to speed decisions, increase transparency, and protect access to medically necessary and emergency care. The inclusion of automatic approval remedies and continuity-of-care protections suggests the bill is designed to curb insurer denials and reduce administrative friction.
The likely areas of contention are the bill’s operational burden and cost implications for insurers, Medicaid, and self-insured plans. Opponents may focus on the 24- and 48-hour deadlines, the requirement to publish clinical review criteria, the restriction on changing prior authorization procedures, and the rule deeming requests approved when deadlines or notice requirements are missed. Public employers and local governments may also object to the unfunded mandate language and the added compliance costs. Supporters are likely to emphasize patient access, emergency-care protections, continuity of treatment, and transparency in coverage decisions.